Rossari Biotech Limited (ROSSARI) — Cash Flow-to-Debt Ratio
Rossari Biotech Limited (ROSSARI) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2023, meaning its operating cash flow of Rs302.28 Million could theoretically repay 0% of its total liabilities (Rs5.56 Billion) in one year. Check ROSSARI cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Rossari Biotech Limited Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Rossari Biotech Limited across 9 annual periods. Also explore total assets of Rossari Biotech Limited for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Rossari Biotech Limited (2017–2025)
Year-by-year debt coverage analysis for Rossari Biotech Limited. For market capitalisation and broader financial context, see ROSSARI stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | Rs1.37 Billion | Rs7.11 Billion | ▲ +134.5% |
| 2024 | 0.08x | Rs432.55 Million | Rs5.24 Billion | ▼ -75.5% |
| 2023 | 0.34x | Rs1.52 Billion | Rs4.52 Billion | ▲ +418.1% |
| 2022 | 0.07x | Rs293.58 Million | Rs4.52 Billion | ▼ -79.2% |
| 2021 | 0.31x | Rs477.67 Million | Rs1.53 Billion | ▲ +5.5% |
| 2020 | 0.30x | Rs548.28 Million | Rs1.85 Billion | ▼ -47.5% |
| 2019 | 0.56x | Rs711.77 Million | Rs1.26 Billion | ▲ +72.0% |
| 2018 | 0.33x | Rs255.69 Million | Rs778.70 Million | ▲ +381.9% |
| 2017 | 0.07x | Rs46.95 Million | Rs689.09 Million | — |